FLSmidth & Co

Modelling the impact of COVID-19, round 2

24/03/20 -"On top of the earnings revision and its impact on the valuation, we have also factored in a lower dividend for the years to come, particularly in FY20-21. Altogether, this leads to a c.15% lower ..."

PDF page sample
Pages
42
Language
English
Published on
24/03/20
Download
You may also be interested by these reports :
17/03/26
We reduce our target price to better reflect current market conditions and a more cautious outlook given the challenges ahead. That said, we continue ...
17/03/26
We have reversed our previous stance from November 2025 regarding a potential £500m equity issuance. This shift is driven by £279m in unforeseen cash ...
17/03/26
Despite the revisions to our DCF and NAV per share, our target price increases only modestly. This is driven by the removal of the premium in the ...
13/03/26
Our opinion on Schindler changes from Reduce to Add as we roll over our model to 2028, and the modest change in our target price results in a ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO